Clinical and Translational Science (Jan 2021)

Collaborations between Clinical Pharmacologists in Japan and in the United States ‐ Report from the IQ CPLG and JPMA CPTF Meeting in Tokyo, Japan

  • Tong Zhu,
  • Makoto Kayama,
  • Sandhya Girish,
  • Vikram Sinha,
  • Akintunde Bello,
  • Atsuhiro Kawaguchi,
  • Richard Czerniak,
  • Lee Nagao

DOI
https://doi.org/10.1111/cts.12853
Journal volume & issue
Vol. 14, no. 1
pp. 102 – 105

Abstract

Read online

The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Clinical Pharmacology Leadership Group (CPLG) held its first meeting of Japan‐based representatives at Astellas Pharma headquarters in Tokyo on October 1, 2019. The meeting was also attended by Japan Pharmaceutical Manufactures Association (JPMA) Clinical Pharmacology Task Force (CPTF) members. Overall, nearly 30 clinical pharmacologists representing 14 companies attended the event. The meeting met its goal of enhancing mutual understanding of each organization’s activities. In a number of break‐out sessions, participants identified scientific topics for potential future collaboration between JPMA CPTF and IQ CPLG.